Hims & Hers Health (HIMS) Cash from Financing Activities (2019 - 2026)

Hims & Hers Health has disclosed Cash from Financing Activities across 8 years of filings, most recently posting $341.8 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 61.56% year-over-year to $341.8 million; the TTM figure through Jun 2026 stood at $127.3 million (down 84.35% YoY), while the FY2025 annual figure was $729.6 million, up 776.55% from the prior year.
• Cash from Financing Activities came in at $341.8 million for Q2 2026 at Hims & Hers Health, up from -$77.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $889.2 million in Q2 2025 to a low of -$97.5 million in Q4 2025.
• Average Cash from Financing Activities over 5 years is $46.7 million, with a median of -$12.1 million recorded in 2022.
• Year-over-year, Cash from Financing Activities sank 13308.97% in 2022 and surged 3647.45% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$10.5 million in 2022, then jumped by 62.11% to -$4.0 million in 2023, then slumped by 244.49% to -$13.7 million in 2024, then slumped by 614.34% to -$97.5 million in 2025, then jumped by 450.44% to $341.8 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $341.8 million in Q2 2026, -$77.9 million in Q1 2026, and -$97.5 million in Q4 2025.